940
Views
3
CrossRef citations to date
0
Altmetric
Review

Successful diabetes management without immunosuppressivedrugs in NHP model has been demonstrated. Encapsulation system with taperednanopore conduits achieved normal glycaemia with regulated insulin release

Pages 1162-1168 | Received 10 Sep 2018, Accepted 28 Sep 2018, Published online: 01 Mar 2019

References

  • Shapiro AMJ, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230–238.
  • Ricordi C. Islet transplantation: a brave new world. Diabetes. 2003;52:1595–1603.
  • Hering BJ, Ricordi C. Islet transplantation in type 1 diabetes: results, research priorities and reasons for optimism. Graft. 1999;2:12–27.
  • Shapiro AMJ, Ricordi C, Hering BJ, et al. International Trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355:1318–1330.
  • Chang TM. Semipermeable microcapsules. Science. 1964;146:524–525.
  • Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science. 1980;210:908–910.
  • Soon-Shiong P, Heintz RE, Merideth N, et al. Insulin independence in a Type 1 diabetic patient after encapsulated islet transplantation. Lancet. 1994;343:950–951.
  • Aebischer P, Hottinger AF, Deglon N. Cellular xenotransplantation. Nat Med. 1999;5:852.
  • Kuhtreiber WM, Lanza RP, Chick WL. Secretary function of biohybrid pancreas devices containing isolated porcine islets. Asaio J. 1994;40:M789–M792.
  • Sun Y, Ma X, Zhou D, et al. Normalization of diabetes in spontaneously diabetic cynomolgus monkeys by xenografts of microencapsulated porcine islets without immunosuppressant. J Clin Invest. 1996;98:1417–1422.
  • Lanza RP, Kuhtreiber WM, Ecker D, et al. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation. 1995;59:1377–1384.
  • Lanza RP, Ecker DM, Kühtreiber WM, et al. Transplantation of islets using microencapsulation: studies in diabetic rodents and dogs. J Mol Med. 1999;77:206–210.
  • Calafiore R, Basta G, Luca G, et al. Transplantation of pancreatic islets contained in minimal volume microcapsules in diabetic high mammalians. Ann N Y Acad Sci. 1999;875:219–232.
  • Scharp D, Schwartz S, Mulgrew P, et al. Encapsulated human islet allografts – phase i/ii clinical trial. Am Diab Meeting Abstr 63-LB. 2006.
  • Weir GC, Bonner-Weir S. Scientific and political impediments to successful islet transplantation. Diabetes. 1997;46(8):1247–1256.
  • Scharp DW, Marchetti P. Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution. Adv Drug Delivery Rev. 2014;67–68:35–73.
  • Wang T, Adcock J, Kühtreiber W. et al. Successful allotransplantation of encapsulated islets in pancreatectomized canines for diabetic management without the use of immunosuppression. Transplantation. 2008;85:331.
  • Sutera SP, Scalar R. The history of Poiseuille's law. Annu Rev Fluid Mech. 1993;25:1–19.
  • De Groot M, Schuurs TA, van Schilfgaarde R. Causes of limited survival of microencapsulated pancreatic islet grafts. J Surgical Res. 2004;121(1):141–150.
  • De Vos P, van Hoogmoed C, van Zanten J, et al. Long-term biocom- patibility, chemistry, and function of microencapsulated pancreatic islets. Biomaterials. 2003;24:305.
  • De Vos P, Van Straate JFM, Nieuwenhuizen AG, et al. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes. 1999;48:1381–1334.
  • Prokop A, Hunkeler D, DiMari S, et al. Water soluble polymer for immunoisolation II: evaluation of multicomponent microencapsulation systems. Adv Polym Sci. 1998;136:1–52 (I), and 53–73 (II).
  • Hunkeler D, Prokop A, Powers A, et al. A screening of polymers as biomaterial for cell encapsulation. Feature Article of Polym News. 1997;22:232–240.
  • Lacik I, Brissova M, Anilkumar AV, et al. New capsule with tailored properties for the encapsulation of living cells. J Biomed Mater Res. 1998;39:52–28.
  • Brissova M, Lacik I, Powers AC, et al. Control and measurement of permeability for design of microcapsule cell delivery system. J Biomed Mater Res. 1998;39:61–29.
  • Huppert HE, Turner JS. Double-diffusive convection. J Fluid Mech. 1981;106:299.
  • Anilkumar AV, Lacik I, Wang TG, A novel reactor for making uniform capsules. Biotechnol Bioeng. 2001;75:581.
  • Deng Q, Anilkumar AV, Wang TG, Role of viscosity and surface tension in bubble entrapment during liquid drop impact onto a deep liquid pool. J Fluid Mech. 2007; 578:119.
  • Mueller KR, Balamurugan AN, Cline GW, et al. Differences in glucose-stimulated insulin secretion in vitro of islets from human, nonhuman primate and porcine origin. Xenotransplantation. 2013;
  • Roth DJ, Jansen ED, Powers AC, et al. A novel method of monitoring response to islet transplantation: bioluminescent imaging of an NF-kB transgenic mouse model. Transplantation. 2006;81:1185.
  • Latif ZA, Noel J, Alejandro R, A simple method of staining fresh and cultured islets. Transplantation. 1988;45:827–830.
  • Ricordi C, Hering BJ, London NJM, et al. Islet isolation assessment. In: RG Landes, ed. Pancreatic islet cell transplantation Vol. 13. Amsterdam: Elsevier; 1992. p. 132–131.
  • Graham ML, Mutch LA, Rieke EF, et al. Refining the high-dose streptozotocin-induced diabetic non-human primate model: an evaluation of risk factors and outcomes. Exp Biol Med (Maywood). 2011;236:1218–1230.
  • Gruessner A, Sutherland DE, Gruessner RW. Pancreas transplantation in the United States: 2010, a review. Curr Opin Organ Transplant. 2010;15:93–10.
  • Fonseca VA, Kirkman MS, Darsow T, et al. The American Diabetes Association diabetes research perspective (Diabetes Care (2012) 35 (1380–1387)). Diabetes Care. 2012;35:1380.
  • Ratner R. Type 2 diabetes mellitus: the grand overview. Diabetes Medicine. 1998;15(Suppl 4):S4–S7.
  • Tuch BE. Stem cells – a clinical update. 2006;35:719–721. PMID 16969445.
  • US Department of Health and Human Services “Stem Cell FAQ”. 2004-07-14. Archived from the original on 2009-01-09. 2014 May.
  • Hering BJ. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nature Medicine 2006;12:301–303.
  • TG, Wang DD. Elleman Method and Apparatus for Producing Concentric Hollow Spheres 4,279,632 (1981);
  • TG, Wang DD. Elleman Method and Apparatus for Producing Gas-Filled Hollow Spheres Shell Forming System 4,344,787 (1982);
  • TG. Wang Shell Forming System 4,960,351 (1990);
  • TG. Wang Method and Apparatus for Producing Uniform Polymeric Spheres 5,260,002 (1993);
  • TG. Wang Semipermeable Microspheres Encapsulating Biological Material. 5,462,866 (1995);
  • T G, Wang, I, Lacik, M, Brissova, et al. Encapsulation System for the Immunisolation of Living Cells 5,997,900 (1999);
  • Wang T G, Anikumar A V, Lacik Igor, A Novel Reactor for Making Uniform Capsules 6,001,312 (1999);
  • Wang TG, Multi-membrane Immunoisolation System for Cellular Transplant. Application no. 11/870366 (2008):
  • T G, Wang Capsule Patches (CP) for Cellular Transplantation without Immunosuppression, 8673294 B2 (2008).
  • T G, Wang Semi-Permeable Capsular Membrane with Tapered conduit for Diabetes Reversal 9,408,807 (2016)
  • T G, Wang Vascularized Patch (VP) of Encapsulated Islets Functions as a BioArtificial Pancreas (BAP). US Patent 48659568 (2017) (Pending)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.